Changes in chronic disease medication adherence following oral anticancer agent initiation in patients with multiple myeloma.

被引：0
|
作者：
Gatwood, Justin
Dashputre, Ankur
Wallace, Alex
Gatwood, Katie S.
Farris, Karen B.
Mackler, Emily R.
Rizvi-Toner, Amna
Rajpurohit, Abhijeet
Farley, Joel
机构：
[1] Univ Tennessee, Coll Pharm, Nashville, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[3] Univ Tennessee, Hlth Sci Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[6] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[7] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[8] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18760
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18760
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions
    Gatwood, Justin
    Dashputre, Ankur
    Rajpurohit, Abhijeet
    Gatwood, Katie
    Mackler, Emily
    Wallace, Leah
    Farris, Karen
    Rizvi-Toner, Amna
    Farley, Joel
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (02) : 342 - 353
  • [32] MYELOMA CAST NEPHROPATHY, LIGHT CHAIN DEPOSITION DISEASE, AND BOTH IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA.
    Lin, Zishan
    Yu, Xiaojuan
    Wang, Suxia
    Zhou, Fude
    Zhao, Minghui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 599 - 599
  • [33] Initiation of generic imatinib may improve medication adherence for patients with chronic myeloid leukemia
    Cole, Ashley L.
    Jazowski, Shelley A.
    Dusetzina, Stacie B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (11) : 1529 - 1533
  • [34] TREATMENT PATTERNS AND MEDICATION ADHERENCE AMONG PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA AND TREATED WITH PANOBINOSTAT
    Gilligan, A. M.
    Bhor, M.
    Stetsovsky, D.
    Varker, H.
    Davis, B. M.
    Eldjerou, L. K.
    Urniasz, A.
    Globe, D.
    Bonafede, M. M.
    VALUE IN HEALTH, 2017, 20 (05) : A88 - A88
  • [35] Treatment patterns and medication adherence among patients diagnosed with multiple myeloma and treated with panobinostat
    Chari, Ajai
    Bhor, Menaka
    Eldjerou, Lamis
    Gilligan, Adrienne M.
    Urniasz, Alyson
    Globe, Denise
    Stetsovsky, Diana
    Varker, Helen
    Davis, Brian
    Bonafede, Machaon
    Talcott, James
    FUTURE ONCOLOGY, 2018, 14 (21) : 2149 - 2160
  • [36] STRUCTURED PATIENT EDUCATION UTILIZING THE MEDICATION ORAL AGENT TEACHING TOOL AND MEDICATION ADHERENCE IN ONCOLOGY PATIENTS PRESCRIBED ORAL CHEMOTHERAPY
    Newman, Virginia
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [37] Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma.
    Dimopoulos, M
    Panayiotidis, P
    Grigoraki, V
    Poziopoulos, C
    Xilouri, I
    Kiamouris, C
    Tassidou, A
    Gika, D
    Stefanoudaki, K
    Anagnostopoulos, N
    Anagnostou, D
    BLOOD, 2001, 98 (11) : 164A - 164A
  • [38] Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease
    Agh, Tamas
    Inotai, Andras
    Meszaros, Agnes
    RESPIRATION, 2011, 82 (04) : 328 - 334
  • [39] Race and associated medication adherence in medicaid enrolled patients with chronic disease
    Balkrishnan, R.
    Uhas, A. A.
    Anderson, R. T.
    VALUE IN HEALTH, 2007, 10 (03) : A27 - A28
  • [40] A Chinese and Western medication adherence scale in patients with Chronic Kidney Disease
    Tan, Jiaowang
    Luo, Li
    Zhang, Min
    Chen, Huifen
    Zhang, Dingjun
    Dong, Chendi
    Xia, Bingqing
    Fu, Lizhe
    Tang, Fang
    Liu, Xusheng
    Tan, Qinxiang
    Wu, Yifan
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 1487 - 1495
12345